VANCOUVER, Feb. 5 /PRNewswire-FirstCall/ - CRH Medical Corporation (CRM:TSX-V) announced today for the year ended December 31, 2007, it had 13,461 patient visits at its Centers for Colorectal Health compared to 1,699 patient visits for the same period in 2006.
Commenting on this achievement, Edward Wright, CEO of CRH Medical Corporation stated, "In 2007, we demonstrated the strong demand for the CRH O'Regan hemorrhoid banding technology and treatment protocol. In 2008, we plan to open several additional Centers in new markets throughout the United States allowing CRH to further capitalize on this large and underserved market. According to the National Institutes of Health the prevalence rate of symptomatic hemorrhoids in the United States is approximately 4.4% of the population or 13.3 million people."
Centers open one year or longer continue to show strong growth, with patient visits increasing 485% for the three months ended December 31, 2007 compared to the same period in 2006.
Commenting on the CRH O'Regan Hemorrhoid Banding technology and treatment protocol, Dr. Iain Cleator, Chief Medical Director of CRH said, "The most important aspect of our technology and treatment protocol is that we are experiencing the same excellent results in each of our Centers. This means that our training methodology and treatment protocol is transferable and reproducible."
Dr. Carolyn Million, Medical Director of CRH's San Francisco Center, added, "As a Fellow of the American Society of Colon and Rectal Surgeons I have treated hemorrhoids for 15 years. In my opinion the CRH O'Regan banding technology and treatment protocol consistently provide a significantly higher level of patient satisfaction compared with other hemorrhoid treatments options."
About CRH Medical Corporation:
CRH Medical Corporation is utilizing the first single use, patented, disposable, hemorrhoid banding system through its Center for Colorectal Health facilities. According to the National Institute of Health approximately 50% of the U.S. population will develop hemorrhoids by age 50. CRH Medical is opening its Center for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids and fissures, and colon cancer screening and plans to significantly increase the number of Centers for Colorectal Health across the U.S. to address this underserved market. The Company's goal is to become the preeminent resource on colorectal health for consumers and medical professionals in North America.
The information in this news release contains so-called
"forward-looking" statements. These include statements regarding CRH
Medical expectations, beliefs, intentions or strategies for the future,
which may be indicated by words or phrases such as "anticipate", "expect",
"intend", "plan", "will", "we believe", "CRH Medical believes", "management
believes" and similar language. All forward-looking statements are based on
CRH Medical current expectations and are subject to risks and uncertainties
and to assumptions made.
The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.
CONTACT: Dean Linden, Investor Relations, CRH Medical Corporation at (604) 633-1440, or firstname.lastname@example.org; Additional information may also be found by visiting the Company's website at http://www.crhmedcorp.com, or the SEDAR website at http://www.sedar.com
|SOURCE CRH Medical Corporation|
Copyright©2008 PR Newswire.
All rights reserved